These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3041540)

  • 1. [Management of a pregnant woman with Streptococcus group B].
    Rudigoz RC; Bensoussan G; Mallecourt P; Delignette M; Desmettre O; Tigaud S; Salvat J
    Rev Fr Gynecol Obstet; 1988 May; 83(5):347-8, 351-4. PubMed ID: 3041540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.
    Boyer KM; Gotoff SP
    N Engl J Med; 1986 Jun; 314(26):1665-9. PubMed ID: 3520319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perinatal Streptococcus agalactiae infections. Clinical epidemiological study and evaluation of a prevention program].
    Bosch J; Ros R; Amorós M; Olivares R; Alvarez E
    Enferm Infecc Microbiol Clin; 1993 Feb; 11(2):70-9. PubMed ID: 8481439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group B streptococcus: the effectiveness of screening and chemoprophylaxis.
    Greenspoon JS; Wilcox JG; Kirschbaum TH
    Obstet Gynecol Surv; 1991 Aug; 46(8):499-508. PubMed ID: 1886704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of neonatal group B streptococcal infection.
    Keenan C
    Am Fam Physician; 1998 Jun; 57(11):2713-20, 2725. PubMed ID: 9636335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.
    Lin FY; Brenner RA; Johnson YR; Azimi PH; Philips JB; Regan JA; Clark P; Weisman LE; Rhoads GG; Kong F; Clemens JD
    Am J Obstet Gynecol; 2001 May; 184(6):1204-10. PubMed ID: 11349189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Colonization by group B hemolytic streptococcus in pregnancy. Note of prevention and therapy of the materno-neonatal infection. Casuistics].
    Della Morte MA; Ratti E; Sala MR; Colombo B
    Pediatr Med Chir; 1996; 18(5):433-50. PubMed ID: 9053881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage.
    McDuffie RS; McGregor JA; Gibbs RS
    Obstet Gynecol; 1993 Oct; 82(4 Pt 1):487-9. PubMed ID: 8377968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic therapy in neonates whose mothers have received intrapartum group B streptococcal chemoprophylaxis.
    Baker CJ
    Pediatr Infect Dis J; 1990 Feb; 9(2):149-50. PubMed ID: 2179842
    [No Abstract]   [Full Text] [Related]  

  • 10. [Obstetrical management of Streptococcus agalactiae].
    Quentin R; Morange-Saussier V; Watt S
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6 Suppl):4S65-4S73. PubMed ID: 12451360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorhexidine vaginal flushings versus systemic ampicillin in the prevention of vertical transmission of neonatal group B streptococcus, at term.
    Facchinetti F; Piccinini F; Mordini B; Volpe A
    J Matern Fetal Neonatal Med; 2002 Feb; 11(2):84-8. PubMed ID: 12375548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of group b streptococcus vertical transmission].
    Andreu Domingo A; Salcedo Abizanda S; Heredia Prim F; González Morlans J; Bartolomé Comas RM; Cabero Roura L
    An Esp Pediatr; 1997 Apr; 46(4):383-8. PubMed ID: 9214233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of intrapartum antibiotics to prevent culture-proved neonatal group B streptococcal sepsis.
    Ascher DP; Becker JA; Yoder BA; Weisse M; Waecker NJ; Heroman WM; Davis C; Fajardo JE; Fischer GW
    J Perinatol; 1993; 13(3):212-6. PubMed ID: 8345385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of a group B streptococcal prophylaxis protocol combining high-risk treatment and low-risk screening.
    Reisner DP; Haas MJ; Zingheim RW; Williams MA; Luthy DA
    Am J Obstet Gynecol; 2000 Jun; 182(6):1335-43. PubMed ID: 10871447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening of Streptococcus agalactiae (group B) in the perinatal period].
    Chaaya A; Chacar HR; Daoud M; Bitar F; Haddad N; Anastabiades E; Haddad M; Mokhbat J
    J Med Liban; 1996; 44(4):203-8. PubMed ID: 9289496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal infection by Streptococcus agalactiae. Multicenter study in the area of Barcelona, Spain].
    Juncosa T; Bosch J; Dopico E; Guardia C; Lite J; Sierra M; Andreu A; Barranco M; Matas L; Sánchez F; Sanfeliu I; Viñas L
    Enferm Infecc Microbiol Clin; 1998; 16(7):312-5. PubMed ID: 9808880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of a rapid screening technique for vaginal carriage of group B Streptococcus during hig-risk pregnancies].
    Auvray C; Decaux J; Deliège R; Delesalle S; Réveil JC
    Pathol Biol (Paris); 1999 May; 47(5):494-6. PubMed ID: 10418026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group B Streptococcus colonization in pregnancy: prevalence and prevention strategies of neonatal sepsis.
    Rausch AV; Gross A; Droz S; Bodmer T; Surbek DV
    J Perinat Med; 2009; 37(2):124-9. PubMed ID: 19021455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.
    Pinto NM; Soskolne EI; Pearlman MD; Faix RG
    J Perinatol; 2003 Jun; 23(4):265-71. PubMed ID: 12774131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of group B streptococcal disease in the newborn.
    Apgar BS; Greenberg G; Yen G
    Am Fam Physician; 2005 Mar; 71(5):903-10. PubMed ID: 15768620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.